Stocks Rise to End a Volatile Week: Stock Market Today
The market's fear index reached and retreated from a six-month intraday peak on Friday as stocks closed the week well.
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered daily
Kiplinger Today
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more delivered daily. Smart money moves start here.
Sent five days a week
Kiplinger A Step Ahead
Get practical help to make better financial decisions in your everyday life, from spending to savings on top deals.
Delivered daily
Kiplinger Closing Bell
Get today's biggest financial and investing headlines delivered to your inbox every day the U.S. stock market is open.
Sent twice a week
Kiplinger Adviser Intel
Financial pros across the country share best practices and fresh tactics to preserve and grow your wealth.
Delivered weekly
Kiplinger Tax Tips
Trim your federal and state tax bills with practical tax-planning and tax-cutting strategies.
Sent twice a week
Kiplinger Retirement Tips
Your twice-a-week guide to planning and enjoying a financially secure and richly rewarding retirement
Sent bimonthly.
Kiplinger Adviser Angle
Insights for advisers, wealth managers and other financial professionals.
Sent twice a week
Kiplinger Investing Weekly
Your twice-a-week roundup of promising stocks, funds, companies and industries you should consider, ones you should avoid, and why.
Sent weekly for six weeks
Kiplinger Invest for Retirement
Your step-by-step six-part series on how to invest for retirement, from devising a successful strategy to exactly which investments to choose.
Stocks opened lower and bounced around the breakeven line before optimism about U.S.-China relations and earnings from banks both big and small took hold among buyers during the last session of the trading week. Trade war and credit concerns ebbed, and a risk-on mood prevailed as a volatile five days ended on positive notes.
In an interview with Fox Business, President Donald Trump acknowledged that a maximum 157% tariffs on exports to the U.S. from China can't go on for long. "It's not sustainable, but that's what the number is," Trump said. "It's probably not, you know, it could stand. But they forced me to do that."
The president also affirmed that he and Chinese President Xi Jinping will meet in South Korea "in a couple of weeks" and expressed optimism about their upcoming talks. "I think we're going to do fine with China. I get along great with him. He's a very strong leader, a very, you know, amazing man," the president said of his counterpart. "But we have to have a fair deal. It's gotta be fair."
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The Cboe Volatility Index (VIX) crested early at 28.99, up from 25.31 on Thursday and as high as it's been since reaching 29.66 on April 24, and fell back to 21.46. The VIX has risen from 16.43 on October 9. A "normal" range for what's widely recognized as the market's "fear index" is between 12 and 20.
At Friday's closing bell, the blue chip Dow Jones Industrial Average was up 0.5% to 46,190 and climbed 1.6% for the week. The broad-based S&P 500 had added 0.5% at 6,664 to extend its five-day gain to 1.7%. The tech-heavy Nasdaq Composite was higher by 0.5% to 22,679 and posted a 2.1% weekly rise.
Is the system full of cockroaches?
Zions Bancorp (ZION, +5.8%) rebounded on Friday after a $50 million charge-off in its third-quarter earnings report caused it to fall 13% and lose about $1 billion in market cap on Thursday.
Regional banks recovered too, though small-cap stocks, as represented by the Russell 2000 Index, saw a 0.6% decline but still finished up 2.4% for the week.
JPMorgan Chase (JPM, -0.3%) CEO Jamie Dimon referred to a couple of regional banks as "cockroaches" during his comments to analysts following his bank's third-quarter earnings report. The comment went viral, and, as Louis Navellier of Navellier & Associates observes, "Several regional banks posted larger-than-expected loan-loss reserves, the highest in three years."
Higher provisions for credit losses "spooked the market and reignited fears of more 'cockroaches' lurking in the banking sector."
On Friday, Baird analyst David George raised his rating on ZION to Outperform (or Buy) from Neutral (or Hold) and reiterated his $65 12-month target price. George said Thursday's sell-off was "overdone," citing "disciplined" loan growth.
"We feel like the panic selling provides a great opportunity to buy ZION shares here," George concluded. "The fraud-related nature of this announcement leads us to believe this is a unique borrower rather than anything systemic."
The membership is spending
American Express (AXP, +7.3%) was the best-performing Dow Jones stock on Friday after management reported earnings of $4.14 per share (+18.6% year over year) on company-record revenue of $18.4 billion (+10.7% YoY). Wall Street expected EPS of $4.00 on revenue of $18 billion.
Management cited higher spending among its affluent customers, as credit card member spend growth accelerated to 9%. Based on its strong year-to-date performance, management raised its full-year guidance to EPS of $15.20 to $15.50 on revenue growth of 9% to 10%.
"The successful launch of our updated U.S. Consumer and Business Platinum Cards reinforces our leadership in the premium space," said CEO Stephen Squeri.
Praxis!
Praxis Precision Medicines (PRAX, +16.8%) enjoyed another big day on the price-action front, adding $500 million more to a market cap that's climbed from just north of $1 billion on Wednesday to near $4 billion.
On Tuesday, management reported positive results for its experimental drug to treat "essential tremor," a nervous system condition that causes involuntary shaking in the hands and arms with no specific treatment yet.
That marked a dramatic counterpoint to a February recommendation by an independent data monitoring committee overseeing the study to stop it "for futility, due to the results being unlikely to meet the primary efficacy endpoint under the parameters set by the statistical model."
Related content
- Five Stocks to Buy for a Trump Presidency
- Kiplinger's Economic Calendar and Analysis for This Week (October 20-24)
- Earnings Calendar and Analysis for This Week (October 20-24)
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

David Dittman is the former managing editor and chief investment strategist of Utility Forecaster, which was named one of "10 investment newsletters to read besides Buffett's" in 2015. A graduate of the University of California, San Diego, and the Villanova University School of Law, and a former stockbroker, David has been working in financial media for more than 20 years.
-
The New Reality for EntertainmentThe Kiplinger Letter The entertainment industry is shifting as movie and TV companies face fierce competition, fight for attention and cope with artificial intelligence.
-
Stocks Sink With Alphabet, Bitcoin: Stock Market TodayA dismal round of jobs data did little to lift sentiment on Thursday.
-
Betting on Super Bowl 2026? New IRS Tax Changes Could Cost YouTaxable Income When Super Bowl LX hype fades, some fans may be surprised to learn that sports betting tax rules have shifted.
-
Stocks Sink With Alphabet, Bitcoin: Stock Market TodayA dismal round of jobs data did little to lift sentiment on Thursday.
-
The 4 Estate Planning Documents Every High-Net-Worth Family Needs (Not Just a Will)The key to successful estate planning for HNW families isn't just drafting these four documents, but ensuring they're current and immediately accessible.
-
Love and Legacy: What Couples Rarely Talk About (But Should)Couples who talk openly about finances, including estate planning, are more likely to head into retirement joyfully. How can you get the conversation going?
-
How to Get the Fair Value for Your Shares When You Are in the Minority Vote on a Sale of Substantially All Corporate AssetsWhen a sale of substantially all corporate assets is approved by majority vote, shareholders on the losing side of the vote should understand their rights.
-
Dow Leads in Mixed Session on Amgen Earnings: Stock Market TodayThe rest of Wall Street struggled as Advanced Micro Devices earnings caused a chip-stock sell-off.
-
How to Add a Pet Trust to Your Estate Plan: Don't Leave Your Best Friend to ChanceAdding a pet trust to your estate plan can ensure your pets are properly looked after when you're no longer able to care for them. This is how to go about it.
-
Want to Avoid Leaving Chaos in Your Wake? Don't Leave Behind an Outdated Estate PlanAn outdated or incomplete estate plan could cause confusion for those handling your affairs at a difficult time. This guide highlights what to update and when.
-
I'm a Financial Adviser: This Is Why I Became an Advocate for Fee-Only Financial AdviceCan financial advisers who earn commissions on product sales give clients the best advice? For one professional, changing track was the clear choice.